(Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, and ...

All before he could even read yet, Alexander Brown had brain surgery, radiation, and two rounds of chemotherapy.

“Today is a day of recognition, but it is also a day of action,” Pradeep Bhide, director of the Florida State University Institute for Pediatric ... posters holding 13 of the 23 IPRD research ...

About NRX-0305 NRX-0305 is a potent, selective, and orally bioavailable mutant-specific BRAF degrader that Nurix is exploring for use in oncology. Nurix has reported preclinical data demonstrating ...

A round-up of news briefs from CT Mirror reporters about this week's happenings at the Connecticut General Assembly.

Seventy-one University of Kentucky students will present their research at the National Conference on Undergraduate Research (NCUR), April 7-9 at Duquesne University in Pittsburgh.

After Hiding My Undiagnosed Neurological Condition for Decades, I Finally Found Answers A personal quest and progress in ...

Patricia A. Prelock, the fourth finalist for a provost post at the University of Arizona, was named interim president at the University of Vermont after Suresh Garimella left for Tucson.

Achievers, the leading recognition and reward platform for employee experience, today announced a joint win with Seattle Children's of a Brandon Hall Group Excellence Award for driving innovation in ...

Rigas recently completed an elective rotation in pediatric hematology and oncology at Upstate Medical ... She delved into these aspects with her graduate research project, “Psychosocial Outcomes in ...